Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: Role of the enzyme paraoxonase-1

British Journal of Dermatology

Volumn 166, Issue 1, 2012, Pages 204-207

  Ferretti, G ^a   Bacchetti, T ^a   Campanati, A ^a   Simonetti, O ^a   Liberati, G ^a   Offidani, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROPEROXIDE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PSORIASIS;

ADULT; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEIN(A); MALE; MIDDLE AGED; OXIDATIVE STRESS; PSORIASIS;

EID: 84555190459     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10539.x     Document Type: Article

References (16)

1. Vizzardi E, Raddino R, Teli M, et al. Psoriasis and cardiovascular diseases. Acta Cardiol 2010; 65: 337-40.
2. Simonetti O, Ferretti G, Salvi A, et al. Plasma lipid changes in psoriatic children. Dermatology 1992; 185: 96-100.
3. Pietrzak A, Michalak-Stoma A, Chodorowska G, Szepietowski JC, Lipid disturbances in psoriasis: an update. Mediators Inflamm 2010; 2010:535612.
4. Tekin NS, Tekin IO, Barut F, Sipahi EY,. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients. Mediators Inflamm 2007; 2007:78454.
5. Coimbra S, Oliveira H, Reis F, et al. Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. J Dermatol Sci 2009; 55: 202-4.
6. Kaur S, Zilmer K, Leping V, Zilmer M,. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. J Eur Acad Dermatol Venereol 2011; 25: 1328-33.
7. Kural BV, Orema A, Cimsit G, et al. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta 2003; 328: 71-82. (Pubitemid 36135781)
8. Kokcam I, Naziroglu M,. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis. Clin Chim Acta 1999; 289: 23-31. (Pubitemid 29505196)
9. Goswami B, Tayal D, Gupta N, Mallika V,. Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 2009; 410: 1-12.
10. Mackness MI, Arrol S, Abbott C, Durrington PN,. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-35. (Pubitemid 24035640)
11. Ferretti G, Bacchetti T, Masciangelo S, et al. Lipid peroxidation in stroke patients. Clin Chem Lab Med 2008; 46: 113-17.
12. Kontush A, Beisiegel U,. Measurement of oxidizability of blood plasma. Methods Enzymol 1999; 299: 35-49. (Pubitemid 28483880)
13. Offidani AM, Ferretti G, Taus M, et al. Lipoprotein peroxidation in adult psoriatic patients. Acta Derm Venereol Suppl (Stockh) 1994; 186: 38-40. (Pubitemid 24208148)
14. Ferretti G, Alleva R, Taus M, et al. Abnormalities of plasma lipoprotein composition and fluidity in psoriasis. Acta Derm Venereol 1994; 74: 171-5. (Pubitemid 24163587)
15. Ferretti G, Bacchetti T, Nègre-Salvayre A, et al. Structural modifications of HDL and functional consequences. Atherosclerosis 2006; 184: 1-7. (Pubitemid 41721062)
16. Morishita R, Ishii J, Kusumi Y, et al. Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vascular wall. J Atheroscler Thromb 2009; 16: 410-18.